However, it has been demonstrated that deleting p53 and RB1 in distinct lung cell types can give rise to different SCLC subtypes, implying that the cell of origin can potentially define the trajectory of tumor progression [21,22]. The gene discussed is TP53; the disease is small cell lung carcinoma.